Digital Dementia Registry Bavaria-digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study.
Nikolas Dietzel, Lara Kürten, Linda Karrer...
https://pubmed.ncbi.nlm.nih.gov/33558357/Actively Recruiting
Led by University of Erlangen-Nürnberg Medical School · Updated on 2026-07-23
5000
Participants Needed
12
Research Sites
N/A
Total Duration
Researchers are studying dementia and mild cognitive impairment in Bavaria, focusing on people living at home with these conditions and their family caregivers. This study aims to improve understanding of the complexity, progression, and care needs of dementia in both urban and rural areas. The research includes people with mild cognitive impairment and mild to moderate dementia as defined by ICD-10 codes and is conducted through a multicenter, prospective, longitudinal registry. Participants include those with mild cognitive impairment or dementia and their family caregivers. Before joining, cognitive tests such as the Mini Mental State Examination and Montreal Cognitive Assessment are used to assess suitability. Participants are interviewed face-to-face at the start, after 6 months, 12 months, and then annually. Recruitment is through various institutions involved in dementia care, including clinics, counseling centers, and outpatient and inpatient facilities across Bavaria. During the study, participants provide detailed information on demographics, health, social and care situations, cognitive assessments, and quality of life measures at multiple timepoints over several years. Researchers collect data on medical history, medication use, cognitive function, social support, internet use, mobility, caregiver burden, and more. This long-term observation helps track changes and care needs up to ten years, with regular follow-up interviews and assessments throughout the study.
CONDITIONS
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers
P
Peter L. Kolominsky-Rabas, Univ.-Prof. Dr. med.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Erlangen-Nürnberg Medical School
Lead Sponsor
Universitätsklinikum Erlangen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants take part in face-to-face interviews and cognitive assessments at baseline, 6 months, 12 months, and then yearly to provide information on health, cognitive function, social support, and care needs.
Interviews at baseline, 6 months, 12 months, and annually thereafter
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nikolas Dietzel, Lara Kürten, Linda Karrer...
https://pubmed.ncbi.nlm.nih.gov/33558357/Michael Reichold, Nikolas Dietzel, Christina Chmelirsch...
https://pubmed.ncbi.nlm.nih.gov/34134149/University of Erlangen-Nürnberg Medical School
Lead Sponsor
Universitätsklinikum Erlangen
Collaborating Sponsor